OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹86 Cr | ₹86 Cr | ₹34 Cr | ₹33 Cr | ₹8.07 Cr |
What is the latest Total Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹86 Cr |
| Mar2025 | ₹86 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹8.07 Cr |
How is Total Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹86 Cr | 0.29 | |
| Mar2025 | ₹86 Cr | 154.78 | |
| Mar2024 | ₹34 Cr | 2.42 | |
| Mar2023 | ₹33 Cr | 307.76 | |
| Mar2022 | ₹8.07 Cr | - | |
Compare Total Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹174.2 Cr | -1.7% | -12.5% | -27% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1.7% |
-12.5% |
-27% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses